EXPE vs TMDX · P/E 20, rev $7.74B vs P/E 17, rev $363.9M
Expedia Group Inc. (EXPE) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the EXPE and TMDX stock pages for the full models.
Not investment advice.